Welcome to our dedicated page for Siriuspoint SEC filings (Ticker: SPNT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SiriusPoint Ltd. (SPNT) SEC filings page on Stock Titan brings together the company’s U.S. regulatory disclosures, including current reports on Form 8-K and other key documents filed with the Securities and Exchange Commission. SiriusPoint is a Bermuda-incorporated global underwriter of insurance and reinsurance whose common shares and 8.00% Resettable Fixed Rate Preference Shares, Series B, are listed on the New York Stock Exchange under the symbols SPNT and SPNT PB. Its filings provide detailed insight into segment performance, capital structure, governance, and material corporate events.
Through its Form 8-K filings, SiriusPoint reports results of operations and financial condition, furnishing earnings press releases, financial supplements, and investor presentations for periods such as the second and third quarters. These documents explain Core results across the Insurance & Services and Reinsurance segments, combined ratios, underwriting income, Core net services income, and book value measures, as well as the impact of catastrophe losses and prior-year reserve development.
The company also uses Form 8-K to disclose material transactions and strategic actions, including the definitive agreement and subsequent completion of the sale of ArmadaCorp Capital, LLC, the holding company of supplemental health insurance program manager ArmadaCare, and the agreement to sell its equity stake in Arcadian Holdings Limited to an acquisition vehicle affiliated with Lee Equity Partners. Related exhibits often include press releases describing associated capacity agreements that extend underwriting authority for Arcadian through at least the end of 2031.
Additional filings cover governance and compensation matters, such as the adoption of the SiriusPoint Ltd. Executive Severance Plan, appointments and resignations of executive officers and directors, and determinations about director independence. SiriusPoint also files 8-Ks to announce quarterly cash dividends on its Series B preference shares, specifying dividend amounts, record dates, and payment dates.
On Stock Titan, these SEC filings are updated as they are released on EDGAR, and AI-powered summaries can help explain the significance of each report. Users can quickly see which filings relate to earnings (such as 10-Q and 10-K when available), which detail insider and executive changes, and which describe major transactions or capital actions, providing a structured view of SiriusPoint’s regulatory history.
Donald Smith & Co., Inc. and its DSCO Value Fund, L.P. report beneficial ownership of SiriusPoint Ltd common stock totaling 6,852,137 shares, representing 5.88% of the class. The filing shows Donald Smith & Co., Inc. holds the bulk of those shares with 6,593,154 shares of sole voting power and sole dispositive power, while DSCO Value Fund, L.P. holds 62,733 shares of sole voting and dispositive power. The reporting persons classify their holdings as held in the ordinary course of business and not for the purpose of influencing control.
This disclosure identifies the issuer as SiriusPoint Ltd and provides the issuer's principal executive office. The filing clarifies that no single advisory client of Donald Smith & Co., Inc. holds more than 5% of the class and states that various persons hold the remaining reported securities.
Capital Research Global Investors filed an amended Schedule 13G reporting beneficial ownership of 5,700,000 shares of SiriusPoint Ltd., representing 4.9% of the approximately 116.6 million shares outstanding. The filing is made under Rule 13d-1(b), indicating a passive disclosure for holdings under 5%. The filing states the shares are held in the ordinary course of business and were not acquired to change or influence control of the issuer. The disclosure clarifies voting and dispositive power are held solely by the reporting person.
On 30 Jul 2025 SiriusPoint Ltd. (NYSE: SPNT) filed an 8-K announcing adoption of an Executive Severance Plan, effective 1 Aug 2025. The plan, approved by the board the same day, governs cash, benefit and equity payouts for two groups: (i) named executives/officers and (ii) other selected employees.
Executives terminated without cause or resigning for Good Reason receive, upon signing a release:
- One-time cash equal to 52 weeks base salary
- Prior-year STI target (if exit ≤ 31 Mar) or pro-rated current-year STI (≥ 1 Apr)
- Immediate vesting of any cash bonus
- Lump-sum of employer-paid medical, dental & vision premiums for 52 weeks
Change-in-Control (CiC): If separation occurs within 12 months of a CiC, cash base-pay and STI amounts are elevated to 150 % of the standard benefit. CiC is defined as: (1) >50 % voting power transfer, (2) sale of substantially all assets, or (3) replacement of a board majority within 24 months.
Other eligible employees receive 2 weeks base pay per year of service (min 6 mths, max 52 wks) plus parallel STI, bonus and benefit terms.
Equity: pro-rated vesting of RSUs/PSUs, extended option exercise (≤3 yrs) and full vesting of buy-out awards.
The plan standardises exit economics and could aid retention during strategic reviews, but it also increases potential cash outflows in layoffs or M&A events.
SiriusPoint (SPNT) Q2-25 10-Q highlights:
- Top line: Net premiums earned rose 10% YoY to $652 m, driven by 15% growth in Insurance & Services and 8% in Reinsurance.
- Underwriting: Combined ratio improved to 89.5% (-3.8 pts YoY) as the attritional loss ratio fell 2 pts and catastrophe losses were negligible (-0.1 pt).
- Income: Net income available to common shareholders dropped 46% YoY to $59.2 m; diluted EPS $0.50 (vs $0.57). The decline reflects lower net investment income (-13%) and a 77% drop in other revenues, partly offset by positive mark-to-market gains ($0.7 m vs -$54.9 m).
- Six-month view: Net premiums earned +8% to $1.28 bn; combined ratio 92.4% (flat). Net income to common $116.8 m (-42%); diluted EPS $0.98 (-7%).
- Balance sheet: Shareholders’ equity rose 9% YTD to $2.11 bn, aided by $51.8 m AFS unrealized gains and $125 m earnings, partially offset by $491 m share buybacks and $8 m preferred dividends.
- Capital actions: Repurchased $490.8 m of common shares YTD; common shares outstanding 116.8 m.
- Liquidity & cash: Operating cash burn narrowed to $26.8 m (vs $91.1 m). Cash & equivalents $923 m; debt $678 m (net increase $39 m).
Key ratios (Q2-25): Loss ratio 56.6%, acquisition cost ratio 26.1%, expense ratio 6.8%. Book value per share ≈ $18.0.
Management reports no material changes to accounting policies and continues to monitor segment profitability via underwriting income and service-fee results.